10-68189064-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS1_Supporting
The NM_032578.4(MYPN):c.2863C>T(p.Arg955Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00054 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R955Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_032578.4 missense
Scores
Clinical Significance
Conservation
Publications
- MYPN-related myopathyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- cap myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated restrictive cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- dilated cardiomyopathy 1KKInheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYPN | NM_032578.4 | c.2863C>T | p.Arg955Trp | missense_variant | Exon 13 of 20 | ENST00000358913.10 | NP_115967.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152170Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000470 AC: 118AN: 250904 AF XY: 0.000406 show subpopulations
GnomAD4 exome AF: 0.000556 AC: 813AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.000560 AC XY: 407AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000381 AC: 58AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:5Benign:1
Reported in association with reduced left-ventricular function, sudden cardiac death and left ventricular non-compaction (PMID: 22892539, 28087566, 28798025); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28087566, 22892539, 23861362, 28798025, 35885997) -
- -
- -
- -
The MYPN c.2863C>T; p.Arg955Trp variant (rs149887823), is reported in the literature in eight individuals with cardiovascular disease or coronary artery disease risk (Meyer 2013, Miszalski-Jamka 2017, Ng 2013, Seidelmann 2017). This variant is also found in the non-Finnish European population with an allele frequency of 0.073% (94/128,690 alleles) in the Genome Aggregation Database. This variant is reported in ClinVar (Variation ID: 192126). Additionally, another variant at this codon (c.2864G>A, p.R955Q) has been reported in individuals with dilated cardiomyopathy as well as in controls, and the pathogenicity has not yet been yet determined (Mazzarotto 2020, Purevjav 2012). The arginine at codon 955 is moderately conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.469). Due to limited information, the clinical significance of the p.Arg955Trp variant is uncertain at this time. References: Mazzarotto F et al. Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy. Circulation. 2020 Feb 4;141(5):387-398. Epub 2020 Jan 27. PMID: 31983221. Meyer T et al. Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet. 2013 Mar;21(3):294-300. PMID: 22892539. Miszalski-Jamka K et al. Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction. Circ Cardiovasc Genet. 2017 Aug;10(4):e001763. PMID: 28798025. Ng et al. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. PMID: 23861362. Purevjav E et al. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Hum Mol Genet. 2012 May 1;21(9):2039-53. doi: 10.1093/hmg/dds022. Epub 2012 Jan 27. PMID: 22286171. Seidelmann SB et al. Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults. Circ Cardiovasc Genet. 2017 Feb;10(1):e001573. PMID: 28087566. -
- -
Dilated cardiomyopathy 1KK Uncertain:4
- -
- -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 955 of the MYPN protein (p.Arg955Trp). This variant is present in population databases (rs149887823, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of dilated cardiomyopathy, left ventricular noncompaction, or sudden cardiac death (PMID: 22892539, 28087566, 28798025). ClinVar contains an entry for this variant (Variation ID: 192126). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3,BS1. -
not specified Uncertain:2
Variant summary: MYPN c.2863C>T (p.Arg955Trp) results in a non-conservative amino acid change located in the immunoglobulin subtype domain (IPR003599) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00047 in 250904 control chromosomes (gnomAD). The observed variant frequency is approximately 9-fold of the estimated maximal expected allele frequency for a pathogenic variant in MYPN causing Cardiomyopathy phenotype (5e-05), suggesting that the variant is benign. c.2863C>T has been reported in the literature in individuals affected with dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular noncompaction or sudden cardiac death (e.g. Meyer_2013, Seidelmann_2017, Miszalski-Jamka_2017, Jaaskelainen_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30775854, 22892539, 28798025, 28087566). ClinVar contains an entry for this variant (Variation ID: 192126). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
The p.Arg955Trp variant in MYPN was identified in 1 Caucasian adult with DCM (Me yer 2013). This variant has also been identified in 48/66700 of European chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs149887823). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg955Trp variant is uncertain. -
Dilated cardiomyopathy 1KK;C4479186:MYPN-related myopathy Uncertain:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at